webmaster-prism

In a world with ever changing needs and demands, especially amongst a global pandemic, issues with the availability of prescription medications continue to challenge the industry. The last words you want to hear as a patient, pharmacist, or sales representative are “out of stock”. The following tips and best practices can help reduce the chances of an issue to begin with: It starts with [...]

The high cost of drugs has become a bipartisan discussion among representatives in Washington, DC. Both the Trump and Biden administrations have taken actions to reduce healthcare spending, and particularly have focused on prescription drug spending. In order to better understand these recent policies and their expected impact on US healthcare payers and manufacturers, Two Labs conducted a panel event with Medical Directors and Pharmacy Directors from managed [...]

Across the board, wholesalers are moving toward inventory optimization – and that makes sense. They’re holding just enough inventory to match demand projections, opting to stay lean and efficient. But while this is the right move for their business, any type of aberration that impacts shipping or demand can cause some serious heartburn for manufacturers, ultimately affecting pharmacies’ abilities to stock product.  It’s up to manufacturers to understand how [...]

The medical device industry is growing, and we’re seeing the impact at Two Labs as more and more clients are asking us for support in launching their new medical device products. The medical device industry is projected to grow 6.8% through 2025. One area of planning that these clients are seeking advice on is state licensing. While the state licensing process for a typical new drug launch may be [...]

During launch planning, many manufacturers place a great deal of emphasis on mapping and understanding the patient journey – and for good reason. The better you understand the patient journey, the better your ability to create a positive patient experience, leading to improved adoption and adherence rates. But while this is important, there’s an equally vital component of the launch strategy that often gets overlooked: mapping the prescriber journey. [...]